Patent Watch: Smoore Targets Controlled Cannabinoid Aerosol Delivery
Patent Watch: Smoore Targets Controlled Cannabinoid Aerosol Delivery
The application’s title identifies cannabis-based aerosol-generating substrates, articles, systems, and methods intended to control cannabinoid delivery through inhalation. The available disclosure does not identify specific cannabinoid active pharmaceutical ingredients, excipients, substrate compositions, or dose-control mechanisms, limiting assessment of formulation novelty and technical differentiation.
Clinical Perspective & Therapeutic Significance
More reproducible inhaled cannabinoid delivery could help patients and clinicians titrate treatment, but delivered dose and systemic exposure would require testing across devices, formulations, and inhalation patterns. The available disclosure establishes neither improved bioavailability nor a validated therapeutic indication, and respiratory safety would depend on aerosol chemistry, operating conditions, and exposure.
Intellectual Property & Market Landscape
Smoore International Holdings Limited is an established aerosol and vaping technology company, positioning this application within its broader delivery-platform business. Compared with conventional cannabis flower and vape cartridges, the proposed distinction is controlled cannabinoid delivery, although the available information does not establish superiority over existing products or identify enforceable claim boundaries.
This application addresses an important challenge in inhaled cannabis: making cannabinoid exposure more predictable. Its clinical significance will depend on demonstrated dosing consistency, respiratory safety, and patient outcomes, not the patent filing alone.
Frequently Asked Questions
Could this technology make inhaled cannabis dosing more predictable?
Does this patent application mean the technology has passed clinical trials?
When could patients obtain a product based on this application?
Get the next evidence review in your inbox
Plain-language summaries of the newest cannabis research, written by a physician. Free to read, and you can unsubscribe at any time.
Join the growing cannabis community. Free. One-click subscribe. Delivered by Substack.